The GIRAFE phase II trial on MVCT-based “volumes of the day” and “dose of the day” addresses when and how to implement adaptive radiotherapy for locally advanced head and neck canc...

by Vincent Esteyrie, Baptiste Gleyzolle, Amélie Lusque, Pierre Graff, Anouchka Modesto, Michel Rives, Michel Lapeyre, Jacques Desrousseaux, Eliane Graulières, Gregory Hangard, François-Xavier Arnaud, Regis Ferrand, Jean-Pierre Delord, Muriel Poublanc, Muriel Mounier, Thomas Filleron, Anne Laprie
Published 2019-05-01